Glycan-Dependent Immunogenicity of Recombinant Soluble Trimeric Hemagglutinin
- 1 November 2012
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 86 (21), 11735-11744
- https://doi.org/10.1128/jvi.01084-12
Abstract
Recombinant soluble trimeric influenza A virus (IAV) hemagglutinin (sHA 3 ) has proven an effective vaccine antigen against IAV. Here, we investigate to what extent the glycosylation status of the sHA 3 glycoprotein affects its immunogenicity. Different glycosylation forms of subtype H5 trimeric HA protein (sH5 3 ) were produced by expression in insect cells and different mammalian cells in the absence and presence of inhibitors of N-glycan-modifying enzymes or by enzymatic removal of the oligosaccharides. The following sH5 3 preparations were evaluated: (i) HA proteins carrying complex glycans produced in HEK293T cells; (ii) HA proteins carrying Man 9 GlcNAc 2 moieties, expressed in HEK293T cells treated with kifunensine; (iii) HA proteins containing Man 5 GlcNAc 2 moieties derived from HEK293S GnTI(−) cells; (iv) insect cell-produced HA proteins carrying paucimannosidic N-glycans; and (v) HEK293S GnTI(−) cell-produced HA proteins treated with endoglycosidase H, thus carrying side chains composed of only a single N -acetylglucosamine each. The different HA glycosylation states were confirmed by comparative electrophoretic analysis and by mass spectrometric analysis of released glycans. The immunogenicity of the HA preparations was studied in chickens and mice. The results demonstrate that HA proteins carrying terminal mannose moieties induce significantly lower hemagglutination inhibition antibody titers than HA proteins carrying complex glycans or single N -acetylglucosamine side chains. However, the glycosylation state of the HA proteins did not affect the breadth of the antibody response as measured by an HA1 antigen microarray. We conclude that the glycosylation state of recombinant antigens is a factor of significant importance when developing glycoprotein-based vaccines, such as recombinant HA proteins.Keywords
This publication has 36 references indexed in Scilit:
- Occluding the Mannose Moieties on Human Immunodeficiency Virus Type 1 gp120 with Griffithsin Improves the Antibody Responses to Both Proteins in MiceAIDS Research and Human Retroviruses, 2012
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan ShieldScience, 2011
- Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategyProceedings of the National Academy of Sciences of the United States of America, 2011
- Towards universal influenza vaccines?Philosophical Transactions Of The Royal Society B-Biological Sciences, 2011
- Influenza vaccinesVaccine, 2009
- Glycans on influenza hemagglutinin affect receptor binding and immune responseProceedings of the National Academy of Sciences of the United States of America, 2009
- Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivoVirology, 2009
- The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stabilityProceedings of the National Academy of Sciences of the United States of America, 2009
- The Strep-tag system for one-step purification and high-affinity detection or capturing of proteinsNature Protocols, 2007
- HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cellsProceedings of the National Academy of Sciences of the United States of America, 2007